CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to optimize a small molecule for pain relief, discovered through collaboration between universities in Portugal and Spain. The molecule shows promise for treating neurodegenerative diseases and will undergo further testing and development with the help of various partners.
BLV200703/4 is a small molecule discovered jointly by groups from the University of Lisbon (Portugal) and Girona (Spain) that proved its efficacy in analgesia from behavioural tests in rats.
The same molecule was tested in a platform that screens potential pharmacological molecules/compounds for neurodegenerative diseases with positive results.
The platform is owned by Bioalvo, SA (Portugal).
The preliminary results so far obtained regarding efficacy and toxicology of the molecule are encouragin…
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Portugal, Lisbon
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Spain, Girona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Tuebingen
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Germany, Tuebingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
